Navigation Links
CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million
Date:5/22/2008

s from future net sales and sublicense of belinostat may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including the risk that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinical studies or from other sources, the success of competing products and technologies, CuraGen's stage of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in CuraGen's Quarterly Report on Form 10-Q for the period ended March 31, 2008 filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any
'/>"/>
SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CuraGen Reports First Quarter 2008 Financial Results
2. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
3. CuraGen Reports Third Quarter 2007 Financial Results
4. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Actifirm Sells Out in First Hour Appearance on QVC
6. Blackstone Sells Gerresheimer Stake
7. Isolagen, Inc. Sells Switzerland Facility
8. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
9. Medifast Franchise Systems Sells First Territory in Baltimore
10. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
11. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... measure damaging "brain tsunamis" in injured patients without ... to reality, thanks to pioneering research at the ... research team, led by Jed Hartings, PhD, research ... the UC College of Medicine, has shown that ... brain like tsunami wavescan be measured by the ...
(Date:9/30/2014)... lung cancer, breast cancer is the leading cause of ... Society. That,s why so many medical professionals encourage women ... at best: only a minority of suspicious mammograms actually ... lots of needless worry for women and their familiesnot ... tests, including ultrasounds and biopsies. , Recently, a ...
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Integrated ... wellness, is opening another new medical specialty practice through ... IMA Cardiology will be located within the company’s ... Abbud and Dr. Isaac Tawfik of American Heart Center, ... The new practice will offer Integrated Medicine Alliance patients ...
(Date:9/30/2014)... 2014(BRONX, NY)Medications are the leading cause of allergy-related sudden ... death certificates from 1999 to 2010, conducted by researchers ... Albert Einstein College of Medicine of Yeshiva University . ... of Allergy and Clinical Immunology , also found that ... high among older people and African-Americans and that such ...
Breaking Medicine News(10 mins):Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3Health News:'Virtual breast' could improve cancer detection 2Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2
... The LFA asks people to join them and show ... FDA-approved medication specifically for lupus , , WASHINGTON, ... Administration (FDA) approved a medication to treat lupus -- when Dwight D. ... effective medications, the Lupus Foundation of America, Inc. (LFA) today launched its ...
... , FLINT, Mich., Sept. 22 Cancer patients residing ... of the most advanced forms of treatment available with a new ... Texas-based health care technology company. , , ... , combines the most advanced treatment capabilities in ...
... , NEW YORK, Sept. 22 Assurant, Inc. ... and insurance-related products and services, will release 2009 third quarter financial results ... will be available on Assurant,s Web site at www.assurant.com ... third quarter conference call at 9:00 a.m. ET on Thursday, Oct. 29, ...
... 22 MedCath Corporation (Nasdaq: MDTH ), a ... diagnosis and treatment of cardiovascular disease, today announced that Art ... Officer effectively immediately. , , Parker ... the company has expanded both the size of its facilities ...
... DENVER, Sept. 22 Anthem Blue Cross and ... has been awarded an Accreditation status of Excellent from the ... that assesses and reports on the quality of the nation,s ... possible level -- is based on a voluntary review of ...
... , , MANHATTAN, Kan., ... Michael Cates, DVM, raised awareness about the One Health Commission at ... Dr. Cates, director of the university,s Master of Public Health Program, ... are very much a "one health" concern. , , ...
Cached Medicine News:Health News:The Lupus Foundation of America, Inc. Asks Supporters to Band Together for Lupus(SM) 2Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 2Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 3Health News:McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan 4Health News:Assurant to Announce 2009 Third Quarter Results Oct. 28, 2009 and Host Webcast Conference Call Oct. 29 2Health News:MedCath Names Art Parker Executive Vice President and Chief Financial Officer 2Health News:Anthem Blue Cross and Blue Shield Awarded NCQA's Accreditation Status of 'Excellent' 2Health News:One Health Commission Teaming Up With World Rabies Day to Spread the 'One Health' Message 2
(Date:9/30/2014)... Sept. 30, 2014  Georgia-Pacific Professional is a ... tissue for a wide range of away from ... product lines in healthcare, including hospitals, long-term care ... is introducing its healthcare products and solutions to ... the importance of infection control in the dental ...
(Date:9/30/2014)... 30, 2014 The report based ... Size, Share, Growth and Forecast, 2007 - 2017," elaborated ... USD 20.8 billion in 2012 and is further expected ... a CAGR of 7.3% from 2012 to 2017. ... health purposes, especially to prevent chronic diseases that may ...
(Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014 /PRNewswire/ ... of U.S. patient-level claims data, anemic chronic kidney ... with their erythropoiesis-stimulating agent (ESA) medication. In addition, ... Janssen,s Procrit. Other key findings ... in Nephrology: An Analysis of Erythropoiesis Stimulating Agents ...
Breaking Medicine Technology:Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
... (NYSE Amex: NBS ) ("NeoStem" or the ... cell based therapeutics development, today announced two appointments to ... Greenacre, an experienced business leader in the biopharmaceutical industry ... and joins as an additional independent director, and Dr. ...
... YORK, Dec. 8, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p090656/Global-Gamma/Scintillation-Cameras-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Camera This report ... in US$ Thousand by the following Product ...
Cached Medicine Technology:NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 2NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 3NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors 4Global Gamma/Scintillation Cameras Industry 2Global Gamma/Scintillation Cameras Industry 3Global Gamma/Scintillation Cameras Industry 4Global Gamma/Scintillation Cameras Industry 5Global Gamma/Scintillation Cameras Industry 6Global Gamma/Scintillation Cameras Industry 7Global Gamma/Scintillation Cameras Industry 8Global Gamma/Scintillation Cameras Industry 9Global Gamma/Scintillation Cameras Industry 10Global Gamma/Scintillation Cameras Industry 11Global Gamma/Scintillation Cameras Industry 12Global Gamma/Scintillation Cameras Industry 13Global Gamma/Scintillation Cameras Industry 14Global Gamma/Scintillation Cameras Industry 15Global Gamma/Scintillation Cameras Industry 16Global Gamma/Scintillation Cameras Industry 17Global Gamma/Scintillation Cameras Industry 18Global Gamma/Scintillation Cameras Industry 19
... is a suture option for ... diameter looped FiberWire products allow ... extensor tendon repairs while reducing ... passes. FiberLoop is available with ...
... study remains the mainstay in a urologic workup. ... patient needs for an accurate, easy-to-use in-office uroflow ... onset of urine flow and automatically ends when ... urine flow. There is no need to have ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
... Ureteral Stents feature teardrop shaped kidney curls ... hydrophilic coating for ease of placement, and ... the trigone. The Multi-Flex advanced design has ... segment provides pushability for placement, and strength ...
Medicine Products: